Verastem, Inc. (VSTM)
5.53
-0.29
(-4.98%)
USD |
NASDAQ |
Mar 20, 16:00
5.54
+0.01
(+0.18%)
After-Hours: 20:00
Verastem EPS Diluted (Quarterly) : -0.3947 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.2719 |
| ADMA Biologics, Inc. | 0.2025 |
| Ocugen, Inc. | -0.0567 |
| Zevra Therapeutics, Inc. | 0.1969 |
| Immuneering Corp. | -0.1793 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.92M |
| Revenue (Quarterly) | 17.54M |
| Total Expenses (Quarterly) | 50.45M |
| Enterprise Value | 367.91M |
| Gross Profit Margin (Quarterly) | 83.51% |
| Profit Margin (Quarterly) | -187.7% |
| Earnings Yield | -60.18% |
| Normalized Earnings Yield | -52.17 |